tiprankstipranks
Biolase assumed with a Buy at Lake Street
The Fly

Biolase assumed with a Buy at Lake Street

Lake Street analyst Frank Takkinen assumed coverage of Biolase with a Buy rating and $1.50 price target. Following a $9.75M follow-on offering, Takkinen thinks the management team now has the needed funding to bridge the company to breakeven, the analyst tells investors in a research note. He says that focus is on the company’s profitability given the lack of profits since its inception, but acknowledges that Biolase’s technology has significant verification and is best in class.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on BIOL:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles